| |
Author |
Title |
Year |
Publication  |
Volume |
Pages |
Links |
|
|
Thomas, A.A.; Abrey, L.E.; Terziev, R.; Raizer, J.; Martinez, N.L.; Forsyth, P.; Paleologos, N.; Matasar, M.; Sauter, C.S.; Moskowitz, C.; Nimer, S.D.; DeAngelis, L.M.; Kaley, T.; Grimm, S.; Louis, D.N.; Cairncross, J.G.; Panageas, K.S.; Briggs, S.; Faivre, G.; Mohile, N.A.; Mehta, J.; Jonsson, P.; Chakravarty, D.; Gao, J.; Schultz, N.; Brennan, C.W.; Huse, J.T.; Omuro, A. |
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma |
2017 |
Neuro-Oncology |
19 |
1380-1390 |
|
|
|
Shahar, T.; Rozovski, U.; Hess, K.R.; Hossain, A.; Gumin, J.; Gao, F.; Fuller, G.N.; Goodman, L.; Sulman, E.P.; Lang, F.F. |
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival |
2017 |
Neuro-Oncology |
19 |
660-668 |
|
|
|
D'Alessandris, Q.G.; Biffoni, M.; Martini, M.; Runci, D.; Buccarelli, M.; Cenci, T.; Signore, M.; Stancato, L.; Olivi, A.; De Maria, R.; Larocca, L.M.; Ricci-Vitiani, L.; Pallini, R. |
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response |
2017 |
Neuro-Oncology |
19 |
1097-1108 |
|
|
|
Goffart, N.; Lombard, A.; Lallemand, F.; Kroonen, J.; Nassen, J.; Di Valentin, E.; Berendsen, S.; Dedobbeleer, M.; Willems, E.; Robe, P.; Bours, V.; Martin, D.; Martinive, P.; Maquet, P.; Rogister, B. |
CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone |
2017 |
Neuro-Oncology |
19 |
66-77 |
|
|
|
Liu, Y.; Shen, Y.; Sun, T.; Yang, W. |
Mechanisms regulating radiosensitivity of glioma stem cells |
2017 |
Neoplasma |
64 |
655-665 |
|
